IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online :50127
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission
 Back To Article

  Reader Comments

Year : 2021 | Volume:  53 | Issue Number:  3

DRUG WATCH

The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study

Chacko Jithin, Dhandapani Shankar, Jahagiridhar Vidhya, Swaminathan Krishnan

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

 

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow